Hainan Province: 5 drugs apply for withdrawal due to rising cost

On April 23, Hainan Provincial Pharmaceutical centralized purchase platform issued the notice on publicizing the information of some newly added and removed drugs, in which 25 drugs of Hengrui, Qilu, Kanghong pharmaceutical and other enterprises were successfully connected to the Internet, and it is worth noting that 14 drugs were removed from the Internet, among which 5 products were removed due to the rising cost All pharmaceutical enterprises and medical institutions: According to the letter on approval of drug networking through quality and efficacy consistency evaluation of generic drugs (qyb [2019] No 114), the letter on approval of drug withdrawal of some enterprises (qyb [2019] No 115) issued by Hainan Medical Security Bureau, as well as the relevant provisions on adding multiple packages, the online letter on approval of some drugs through quality and efficacy consistency evaluation of generic drugs is hereby sent Some enterprises apply to cancel the drug information on the Internet and apply to add multi package drug information for publicity (see Annex 1, 2 and 3) The publicity period is from April 23 to April 25, 2019 If you have any objection to the publicity information, please submit written materials to our center within the publicity period (Tel: 0898-66529803, QQ: 750109782 for consultation) After the end of the publicity period, our center will hang or remove the network for the varieties without objection Notice is hereby given Annex 1: online information publicity form of conformity evaluation drugs (April 23, 2019) Annex 2: online information publicity form of withdrawal drugs (April 23, 2019) Annex 3: multi package drug information publicity form (April 23, 2019) added by Hainan public resources trading service center April 23, 2019 online information publicity form of conformity evaluation drugs online withdrawal drug information publicity form added by multi package drug information publicity form